Literature DB >> 15843171

Varicella-zoster virus IE63 protein represses the basal transcription machinery by disorganizing the pre-initiation complex.

Emmanuel Di Valentin1, Sébastien Bontems, Lionel Habran, Olivier Jolois, Nicolas Markine-Goriaynoff, Alain Vanderplasschen, Catherine Sadzot-Delvaux, Jacques Piette.   

Abstract

Using transient transfection assays, regulation properties of varicella-zoster virus (VZV)-encoded IE63 protein were analyzed on several VZV immediate early (ORF4), early (ORF28) and late (ORF67) promoters. IE63 was shown to repress the basal activity of most of the promoters tested in epithelial (Vero) and neuronal (ND7) cells to various extents. Trans-repressing activities were also observed on heterologous viral and cellular promoters. Since a construct carrying only a TATA box sequence and a series of wild-type or mutated interleukin (IL)-8 promoters was also repressed by IE63, the role of upstream regulatory elements was ruled out. Importantly, the basal activity of a TATA-less promoter was not affected by IE63. Using a series of IE63 deletion constructs, amino acids 151-213 were shown to be essential to the trans-repressing activity in Vero cells, while in ND7 cells the essential region extended to a much larger carboxy-terminal part of the protein. We also demonstrate that IE63 is capable of disrupting the transcriptional pre-initiation complex and of interacting with several general transcription factors. The central and carboxy-terminal domains of IE63 are important for these effects. Altogether, these results demonstrate that IE63 protein is a transcriptional repressor whose activity is directed towards general transcription factors.

Entities:  

Mesh:

Substances:

Year:  2005        PMID: 15843171     DOI: 10.1515/BC.2005.031

Source DB:  PubMed          Journal:  Biol Chem        ISSN: 1431-6730            Impact factor:   3.915


  18 in total

1.  Varicella zoster virus infection of human fetal lung cells alters mitochondrial morphology.

Authors:  Amy C Keller; Hussain Badani; P Mason McClatchey; Nicholas L Baird; Jacqueline L Bowlin; Ron Bouchard; Guey-Chuen Perng; Jane E B Reusch; Benedikt B Kaufer; Don Gilden; Aamir Shahzad; Peter G E Kennedy; Randall J Cohrs
Journal:  J Neurovirol       Date:  2016-05-31       Impact factor: 2.643

2.  Recombinant monoclonal antibody recognizes a unique epitope on varicella-zoster virus immediate-early 63 protein.

Authors:  Niklaus H Mueller; Nathan L Bos; Scott Seitz; Mary Wellish; Ravi Mahalingam; Don Gilden; Randall J Cohrs
Journal:  J Virol       Date:  2012-03-21       Impact factor: 5.103

Review 3.  A comparison of herpes simplex virus type 1 and varicella-zoster virus latency and reactivation.

Authors:  Peter G E Kennedy; Joel Rovnak; Hussain Badani; Randall J Cohrs
Journal:  J Gen Virol       Date:  2015-03-20       Impact factor: 3.891

4.  Nuclear import of the varicella-zoster virus latency-associated protein ORF63 in primary neurons requires expression of the lytic protein ORF61 and occurs in a proteasome-dependent manner.

Authors:  Matthew S Walters; Christos A Kyratsous; Shilin Wan; Saul Silverstein
Journal:  J Virol       Date:  2008-06-18       Impact factor: 5.103

5.  Identification of phosphorylated residues on varicella-zoster virus immediate-early protein ORF63.

Authors:  Niklaus H Mueller; Matthew S Walters; Roland A Marcus; Laurie L Graf; Jessica Prenni; Don Gilden; Saul J Silverstein; Randall J Cohrs
Journal:  J Gen Virol       Date:  2010-01-20       Impact factor: 3.891

6.  Downregulation of varicella-zoster virus (VZV) immediate-early ORF62 transcription by VZV ORF63 correlates with virus replication in vitro and with latency.

Authors:  Susan E Hoover; Randall J Cohrs; Zoila G Rangel; Donald H Gilden; Peter Munson; Jeffrey I Cohen
Journal:  J Virol       Date:  2006-04       Impact factor: 5.103

7.  Construction of recombinant mouse IgG1 antibody directed against varicella zoster virus immediate early protein 63.

Authors:  Niklaus H Mueller; Laurie L Graf; Andrew J Shearer; Gregory P Owens; Donald H Gilden; Randall J Cohrs
Journal:  Hybridoma (Larchmt)       Date:  2008-02

8.  Development of recombinant varicella-zoster viruses expressing luciferase fusion proteins for live in vivo imaging in human skin and dorsal root ganglia xenografts.

Authors:  Stefan L Oliver; Leigh Zerboni; Marvin Sommer; Jaya Rajamani; Ann M Arvin
Journal:  J Virol Methods       Date:  2008-09-24       Impact factor: 2.014

9.  Varicella-zoster virus modulates NF-kappaB recruitment on selected cellular promoters.

Authors:  Nadia El Mjiyad; Sébastien Bontems; Geoffrey Gloire; Julie Horion; Patricia Vandevenne; Emmanuel Dejardin; Jacques Piette; Catherine Sadzot-Delvaux
Journal:  J Virol       Date:  2007-09-12       Impact factor: 5.103

10.  Varicella-zoster virus immediate-early 63 protein interacts with human antisilencing function 1 protein and alters its ability to bind histones h3.1 and h3.3.

Authors:  Aruna P Ambagala; Trent Bosma; Mir A Ali; Maxim Poustovoitov; Jason J Chen; Michael D Gershon; Peter D Adams; Jeffrey I Cohen
Journal:  J Virol       Date:  2008-10-29       Impact factor: 5.103

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.